Perioperative management of patients with pulmonary hypertension for non-cardiac surgery

Current Rheumatology Reports
Elaine I Yang

Abstract

Pulmonary hypertension (PH) is associated with significant morbidity and mortality. While the advent of disease-modifying therapies in the treatment of PH has dramatically increased the life expectancy of these patients, they remain at high risk for perioperative complications. Outcome studies suggest that patients with PH undergoing non-cardiac surgery have higher morbidity and mortality than those without, independent of severity. Despite these risks, more and more of these patients are presenting for non-cardiac surgery. Patients with rheumatologic disorders in particular often have pulmonary arterial hypertension (PAH), a group that is associated with a poorer prognosis. Yet, these patients invariably develop debilitating joint diseases and not uncommonly present for elective surgery. Preoperatively, patients with PH should be appropriately risk stratified based on functional class, etiology, exercise capacity, pulmonary hemodynamics, and the risk of surgery. If the risks and benefits assessment proves favorable, they should undergo optimization prior to surgery, with any chronic therapy continuing without cessation through the perioperative period. A multidisciplinary approach involving all intraoperative physicians is imp...Continue Reading

References

Aug 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·W P ArnoldF Murad
Mar 1, 1966·The Journal of Clinical Investigation·A M Rudolph, S Yuan
Jun 17, 1993·The New England Journal of Medicine·A GiaidD J Stewart
Jul 29, 2000·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·M J KrowkaR A Krom
Nov 7, 2003·The Annals of Thoracic Surgery·Stuart W JamiesonWilliam R Auger
Nov 26, 2003·Anesthesiology·Gilbert BlaiseBernard Hubert
Apr 16, 2004·The European Respiratory Journal·P DartevelleG Simonneau
May 17, 2005·Journal of the American College of Cardiology·Gautam RamakrishnaMichael D McGoon
Aug 3, 2006·Nature Reviews. Drug Discovery·Hossein A GhofraniFriedrich Grimminger
Jun 20, 2007·British Journal of Anaesthesia·H-C LaiT-J Liu
May 29, 2008·Circulation·Nazzareno GalièUNKNOWN Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Studies
Jul 9, 2009·Journal of the American College of Cardiology·Nicholas W MorrellE Kenneth Weir
Jul 9, 2009·Journal of the American College of Cardiology·Marius M HoeperMichael McGoon
Nov 10, 2009·The European Respiratory Journal·L C PriceM Humbert
Sep 16, 2010·Anesthesia and Analgesia·Stavros G MemtsoudisMadhu Mazumdar
Jun 28, 2011·American Journal of Respiratory and Critical Care Medicine·Marius M Hoeper, John Granton
Aug 13, 2011·Journal of the American College of Cardiology·Rachel J LeGarvan C Kane
Nov 13, 2012·The European Respiratory Journal·Stephanie MeyerMarc Humbert
Apr 23, 2013·American Journal of Respiratory and Critical Care Medicine·Adriano R TonelliRaed A Dweik
May 21, 2013·Annals of the Rheumatic Diseases·J Gerry CoghlanUNKNOWN DETECT study group
Dec 21, 2013·Journal of the American College of Cardiology·Gerald SimonneauRogiero Souza
Dec 21, 2013·Journal of the American College of Cardiology·Marius M HoeperDavid B Badesch
Dec 21, 2013·Journal of the American College of Cardiology·Nazzareno GalièAnne Keogh
Dec 21, 2013·Journal of the American College of Cardiology·Vallerie V McLaughlinOlivier Sitbon
Jan 21, 2014·Current Opinion in Rheumatology·Mandana Nikpour, Murray Baron
May 16, 2014·Seminars in Cardiothoracic and Vascular Anesthesia·Daniel L FoxTodd Bull
May 31, 2014·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Maria WieteskaAdam Torbicki
Jul 23, 2014·HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery·David KimYan Ma
Sep 3, 2014·La Presse médicale·Mohamed A GashoutaPaul M Hassoun
Sep 10, 2014·Current Opinion in Rheumatology·Kristin B Highland

❮ Previous
Next ❯

Citations

May 3, 2019·Der Anaesthesist·S DehneR von Haken
Jul 18, 2020·Obesity Surgery·Ahmed Abdallah SalmanHani Maurice Sabri Mikhail
Jun 29, 2018·Updates in Surgery·Loka ThangamathesvaranAziz M Merchant
Feb 6, 2021·Clinics in Chest Medicine·Jochen Steppan, Paul M Heerdt
Dec 24, 2021·European Respiratory Review : an Official Journal of the European Respiratory Society·Debabrata BandyopadhyayMarc Humbert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.